Propanc Biopharma, Inc. Share Price
NASDAQ: PPCB$0.00
+0.00 (0.00%) Propanc Biopharma, Inc. Stock Performance
Propanc Biopharma, Inc. Share Price Chart
$0.00$0.00
L
H
Propanc Biopharma, Inc. Quarterly Profit & Loss
All figures in USD
Propanc Biopharma, Inc. Annual Profit & Loss
All figures in USD
About Propanc Biopharma, Inc.
Propanc Biopharma Inc is a development-stage healthcare company. It focuses on developing new cancer treatments for patients suffering from pancreatic, ovarian, and colorectal cancer. The company develops a rational, composite formulation of the anti-cancer compound, which together exert a number of effects designed to control or prevent tumors from recurring and spreading through the body. Its product, PRP, is a variation upon its novel formulation and involves proenzymes, the inactive precursors of enzymes.
Propanc Biopharma, Inc. Historical Returns
| Month | Open | Close | Change % |
|---|---|---|---|
Nov 2026 | $1.90 | $1.95 | +5.98% |
Oct 2026 | $0.49 | $1.84 | +268.00% |
Sep 2026 | $1.24 | $0.50 | -77.27% |
Aug 2026 | $1.15 | $2.20 | +120.00% |
Jul 2026 | $1.49 | $1.00 | -35.90% |
Jun 2026 | $1.84 | $1.56 | -10.60% |
May 2026 | $0.10 | $1.75 | +1,610.78% |
Apr 2026 | $0.11 | $0.10 | -8.93% |
Mar 2026 | $0.18 | $0.11 | -42.56% |
Feb 2026 | $0.22 | $0.20 | -11.36% |
Jan 2026 | $0.57 | $0.22 | -58.96% |
Dec 2025 | $1.09 | $0.54 | -37.89% |